TNFα mRNA and protein in cardiac transplant biopsies: Comparison with serum TNFα levels

Cardiovascular Research

Volumn 32, Issue 3, 1996, Pages 551-556

  Azzawi, May ^a   Grant, Simon D C ^b   Hasleton, Philip S ^b   Yonan, Nizar ^b   Campbell, Colin S ^b   Deiraniya, Abdul K ^b   Rahman, Ali ^b   Hutchinson, Ian V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Heart transplantation; Human; Immunohistochemistry; Rejection

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

ADULT; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MYOCARDIUM; RNA; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030246953     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00101-0     Document Type: Article

References (29)

1. [1] Wong GHW, Tartaglia LA, Lee MS, Goeddell DV. Antiviral activity of TNF is signaled through the 55kDa receptor, type I TNF. J Immunol 1992;149:3350.
2. [2] Gordon HM, Kucera G. Salvo R. Boss JM. TNF induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts. J Immunol 1992;148:4021.
3. [3] Imagawa DK, Millis JM, Olthoff KM. et al. The role of TNF in allograft rejection. II. Evidence that antibody therapy against TNFα and lymphotoxin enhances cardiac allograft survival in rats. Transplantation 1990;50:189.
4. [4] Lin H, Chensue SW, Strieter RM, et al. Antibodies against tumour necrosis factor prolong cardiac allograft survival in the rat. J Heart Lung Transplant 1992;11:330.
5. [5] Mclaughlin PJ, Aikawa A, Davies HM, et al. Evaluation of sequential plasma and urinary tumour necrosis factor levels in renal allograft recipients. Transplantation 1991;51:1225.
6. [6] Chollet-Martin S, Depoix JP, Hvass Y, et al. Raised plasma levels of TNF in heart allograft rejection. Transplant Proc 1990;22:283.
7. [7] Arbustini E, Grasso M, Diegole M, et al. Expression of TNF-alpha in human acute cardiac rejection. Am J Pathol 1991;139:709.
8. [8] Rakhmilevich AL, North RJ, Dye ES. Evidence inconsistent with a role for tumour necrosis factor in tumor allograft rejection. Transplantation 1993;55:182.
9. [9] Stevens HPJD, van der Kwast TH, van der Meide PH, Vuzevski VD, Buurman WA, Jonker M. Synergistic immunosuppressive effects of monoclonal antibodies specific for interferon-gamma and tumor necrosis factor alpha: a skin transplantation study in the rhesus monkey. Transplantation 1990;50:856.
10. [10] Vandenbroecke C, Caillat-Zucman S, Legendre C, et al. Differential in situ expression of cytokines in renal allograft rejection. Transplantation 1991;51:602.
11. [11] Declaration of Helsinki. Br Med J 1964;ii:177.
12. [12] Billingham ME, Nathaneil RB, Carey NRB, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 1990;9:587.
13. [13] Azzawi M, Hasleton PS, Grant SCD, Stewart J, Hutchinson, IV. Interleukin-10 in human cardiac transplantation - an in situ hybridisation study. J Heart Lung Transplant 1995;14:519-528.
14. [14] Robert B, Sassoon D, Jacq B, Gehring W, Buckingham M. Hox-7, a mouse homeobox gene with a novel pattern of expression during embryogenesis. EMBO J 1989;8:91.
15. [15] Sternberger LA. The unlabelled antibody enzyme peroxidase-anti-peroxidase (PAP) method. In: Immunocytochemistry. Sternberger LA. New York: John Wiley, 1979:104-169.
16. [16] McCall JL, Kankatsu Y, Funamoto S, Parry BR. In vivo immunohistochemical identification of TNF/cachectin in human lymphoid tissue. Am J Pathol 1989;135:421.
17. [17] Mason DY, Sammons RE. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 1978;31:454-460.
18. [18] Kelly PMA, Bliss E, Morton JA, Burns J, McGee JO'D. Monoclonal antibody EBM-11: high cellular specificity for human macrophages. J Clin Pathol 1988;41:510.
19. [19] Lamb WR, Pumphrey RSH, Brenchley PEC. A peroxidase-linked enzyme immunoassay for tumour necrosis factor alpha utilising alternative colorimetric or chemilumimetric substrates. J Immunol Methods 1992;155:215.
20. [20] Maury CPJ, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor in renal allograft rejection. J Exp Med 1987;166:1132.
21. [21] Grim PC, McKenna RM, Gospodarek EM, Jeffery JR, Rush DN. Low frequency of infiltrating cells intensely expressing T cell cytokine mRNA in human renal allograft rejection. Transplantation 1995;59:579.
22. [22] Ruddle NH. Tumour necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opinion Immunol 1992;4:327.
23. [23] Remick DG, Scales WE, May MA, Spengler M, Nguyen D, Kunkel S. In situ hybridisation analysis of macrophage derived tumor necrosis factor and interleukin-1 mRNA. Lab Invest 1988;59:809.
24. [24] Goldfeld AE, McCaffrey PG, Strominger JL, Rao A. Identification of a novel cyclosporin-sensitive element in the human TNF-alpha gene promoter. J Exp Med 1993;178:1365.
25. 1 model of acute graft versus host disease. Transplantation 1995;59:890.
26. [26] Grant SCD, Lamb WR, Gallati H, et al. Release of TNF-alpha, IL-6, and the TNF receptors p55 and p75 following ATG therapy in heart and heart/lung transplant recipients. J Heart Lung Transplant 1993;12:S72.
27. [27] Debets JMH, Leunissen KML, VanHooff HJ, Van der Linden CJ, Burman WA. Evidence of involvment of TNF in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin. Transplantation 1989;47:487.
28. [28] Grant SCD, Lamb WR, Hutchinson IV, Brenchley PEC. Serum soluble adhesion molecules and cytokines in cardiac allograft rejection. Transplant Immunol 1994;2:321.
29. [29] Serrick C, Adoumie R, Giaid A, Shennib H. The early release of Interleukin-2, tumor necrosis factor and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994;58:1158.